Literature DB >> 29980656

Differences Between Patients Enrolled Early and Late During Clinical Trial Recruitment: Insights From the HF-ACTION Trial.

Haider J Warraich1,2, Christopher O'Connor3, Angie Wu4, Adrian Coles4, William E Kraus2, Ileana L Piña5, David J Whellan6, Robert J Mentz4,2.   

Abstract

Entities:  

Keywords:  cardiac resynchronization therapy; exercise test; heart failure; outpatients; prevalence

Mesh：

Year:  2018        PMID： 29980656      PMCID： PMC6070357          DOI： 10.1161/CIRCOUTCOMES.117.004643

Source DB:  PubMed          Journal:  Circ Cardiovasc Qual Outcomes        ISSN： 1941-7713


× No keyword cloud information.
  4 in total

1.  Temporal trends in clinical characteristics, treatments, and outcomes for heart failure hospitalizations, 2002 to 2004: findings from Acute Decompensated Heart Failure National Registry (ADHERE).

Authors:  Gregg C Fonarow; J Thomas Heywood; Paul A Heidenreich; Margarita Lopatin; Clyde W Yancy
Journal:  Am Heart J       Date:  2007-06       Impact factor: 4.749

2.  Trial watch: Clinical trial cycle times continue to increase despite industry efforts.

Authors:  Linda Martin; Melissa Hutchens; Conrad Hawkins
Journal:  Nat Rev Drug Discov       Date:  2017-02-10       Impact factor: 84.694

3.  Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model.

Authors:  Christopher M O'Connor; David J Whellan; Daniel Wojdyla; Eric Leifer; Robert M Clare; Stephen J Ellis; Lawrence J Fine; Jerome L Fleg; Faiez Zannad; Steven J Keteyian; Dalane W Kitzman; William E Kraus; David Rendall; Ileana L Piña; Lawton S Cooper; Mona Fiuzat; Kerry L Lee
Journal:  Circ Heart Fail       Date:  2011-11-23       Impact factor: 8.790

4.  Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.

Authors:  Christopher M O'Connor; David J Whellan; Kerry L Lee; Steven J Keteyian; Lawton S Cooper; Stephen J Ellis; Eric S Leifer; William E Kraus; Dalane W Kitzman; James A Blumenthal; David S Rendall; Nancy Houston Miller; Jerome L Fleg; Kevin A Schulman; Robert S McKelvie; Faiez Zannad; Ileana L Piña
Journal:  JAMA       Date:  2009-04-08       Impact factor: 56.272
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.